Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American College of Cardiology

• Publication date

  2005-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2004.09.076PMID 15708698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metoprolol treatment after acute myocardial infarction. Effects on ventricular arrhythmias and exercise tests during 6 months.

  2009cited by this paper
• Effect of timolol on late ventricular arrhythmias after acute myocardial infarction.

  2009cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

  2003cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.

  2002cited by this paper
• Antiarrhythmic drug carvedilol inhibits HERG potassium channels.

  2001cited by this paper
• Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

  2001cited by this paper
• Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.

  2000cited by this paper
• The Inhibitory Effects of Carvedilol Against Arrhythmias Induced by Coronary Reperfusion in Anesthetized Rats

  2000cited by this paper
• New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.

  2000cited by this paper
• Design and methodology of the CAPRICORN trial — a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction

  2000cited by this paper
• The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.

  1999cited by this paper
• Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

  1999cited by this paper
• Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction. Randomized, placebo-controlled substudy of ISIS-4.

  1996cited by this paper
• Ventricular Arrhythmias in the Acute and Chronic Phases After Acute Myocardial Infarction: Effect of Intervention With Captopril

  1994cited by this paper
• Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS).

  1994cited by this paper
• Prevalence and Prognostic Significance of Ventricular Arrhythmias After Acute Myocardial Infarction in the Fibrinolytic Era GISSI‐2 Results

  1993cited by this paper
• Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction

  1992cited by this paper
• Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group.

  1992cited by this paper
• Effects of β-Blockade on the Incidence of Ventricular Tachyarrhythmias during Acute Myocardial Ischemia: Experimental Findings and Clinical Implications

  1991cited by this paper
• Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.

  1990cited by this paper
• Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.

  1990cited by this paper
• Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.

  1988cited by this paper
• Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias.

  1987cited by this paper
• Metoprolol in acute myocardial infarction reduces ventricular arrhythmias both in the early stage and after the acute event.

  1987cited by this paper
• Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.

  1986cited by this paper
• Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group.

  1985cited by this paper
• Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.

  1985cited by this paper
• Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group

  1985cited by this paper
• A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias.

  1983cited by this paper
• Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.

  1983cited by this paper
• Risk stratification and survival after myocardial infarction.

  1983cited by this paper
• Metoprolol in acute myocardial infarction.

  1982cited by this paper
• Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical Studies

  1982cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Intravenous and oral practolol in the acute stages of myocardial infarction.

  1978cited by this paper
• Intravenous and oral practolol in the acute stages of myocardial infarction.

  1978cited by this paper
• THE SIMIAN CREASE.

  1964cited by this paper

• Managing Atrial Fibrillation in Heart Failure: In Whom, When, and How?

  2026cites this paper
• Early catheter ablation versus conservative- only management in patients with electrical storm. Systematic review and meta- analysis.

  2025cites this paper
• Outcomes and Management of Stressor-Associated Atrial Fibrillation: JACC State-of-the-Art Review.

  2025cites this paper
• Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure

  2025cites this paper
• Determining major adverse cardiovascular event risk of beta-blocker discontinuation after acute coronary syndromes

  2025cites this paper
• The Role of Oral β-Blockers in Patients With Acute Myocardial Infarction with Preserved or Mildly Reduced Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Neuropeptide Y Drives Ventricular Arrhythmogenesis in Chronic Ischemic Heart Failure via Calcium Mishandling.

  2025cites this paper
• European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

  2025cites this paper
• Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2025cites this paper
• Temporal order of atrial fibrillation and acute myocardial infarction and associated prognosis in the Danish Diet, Cancer and Health cohort

  2025cites this paper
• β-blocker and clinical outcomes in patients after myocardial infarction: a systematic review and meta-analysis

  2025cites this paper
• The Role of Infarct Border Zone Remodelling in Ventricular Arrhythmias: Bridging Basic Research and Clinical Applications

  2025cites this paper
• Exploring the Impact of Beta-Blockers Post-Acute Myocardial Infarction in Patients with Preserved Ejection Fraction: A Meta-Analysis

  2025cites this paper
• Prognostic impact of early and late newly diagnosed atrial fibrillation in acute myocardial infarction treated with percutaneous coronary intervention

  2025cites this paper
• Fibrilación auricular de novo en síndrome coronario agudo

  2024cites this paper
• Vericiguat suppresses ventricular tachyarrhythmias inducibility in a rabbit myocardial infarction model

  2024cites this paper
• Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.

  2024cites this paper
• Bidirectional Association Between Atrial Fibrillation and Myocardial Infarction, and Relation to Mortality in the Framingham Heart Study

  2024cites this paper
• Atrial Fibrillation Management with Guideline-Directed Medical Therapy and Comorbidity Treatment in Heart Failure Patients.

  2024cites this paper
• 2024 Clinical practice guidelines for Chronic heart failure

  2024cites this paper
• Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations

  2024cites this paper
• Routine beta‐blocker therapy after acute coronary syndromes: The end of an era?

  2024cites this paper
• Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)

  2024cites this paper
• Lifestyle changes in atrial fibrillation management and intervention

  2023cites this paper
• SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta‐analysis of randomized clinical trials

  2023cites this paper
• Comparing the Efficacy of Carvedilol and Flecainide on the Treatment of Idiopathic Premature Ventricular Complexes from Ventricular Outflow Tract: A Multicenter, Randomized, Open-Label Pilot Study

  2023cites this paper
• Effect of β1-adrenergic receptor gene polymorphism on ventricular arrhythmia and prognosis after myocardial infarction

  2023cites this paper
• Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it

  2023cites this paper
• Consensus Recommendations of the Asia Pacific Cardiometabolic Consortium on Secondary Prevention Strategies in Myocardial Infarction: Recommendations on Pharmacotherapy, Lifestyle Modification and Cardiac Rehabilitation

  2023cites this paper
• The bidirectional association between atrial fibrillation and myocardial infarction

  2023cites this paper
• Overview of Cardiac Arrhythmias and Treatment Strategies

  2023cites this paper
• Arrhythmias After Acute Myocardial Infarction

  2023cites this paper
• Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction.

  2022cites this paper
• Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs

  2022cites this paper
• Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.

  2022cites this paper
• JCS 2018 Guideline on Revascularization of Stable Coronary Artery Disease.

  2022cites this paper
• Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.

  2022cites this paper
• Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction

  2022cites this paper
• Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines

  2021cites this paper
• Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF

  2021cites this paper
• Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management

  2021cites this paper
• Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism

  2021cites this paper
• Efficacy of amiodarone in the treatment of ventricular arrhythmias in patients with coronary artery disease in Bangladesh

  2021cites this paper
• Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives

  2021cites this paper
• Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020

  2021cites this paper
• Cytoprotective Potential of Aged Garlic Extract (AGE) and Its Active Constituent, S-allyl-l-cysteine, in Presence of Carvedilol during Isoproterenol-Induced Myocardial Disturbance and Metabolic Derangements in Rats

  2021cites this paper
• Perspective on the role of four beta-blockers in heart failure.

  2021cites this paper
• Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

  2021cites this paper
• Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.

  2020cites this paper
• Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes

  2020cites this paper
• Effect of carvedilol on premature ventricular complexes originating from the ventricular outflow tract

  2020cites this paper
• Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation

  2020cites this paper
• Хроническая сердечная недостаточность. Клинические рекомендации 2020

  2020cites this paper
• New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke

  2020cites this paper
• Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2020cites this paper
• Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2020cites this paper
• Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence

  2020cites this paper
• EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)

  2020cites this paper
• Statins reduce new-onset atrial fibrillation after acute myocardial infarction

  2020cites this paper
• New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality

  2019cites this paper
• Heart failure as a substrate and trigger for ventricular tachycardia

  2019cites this paper
• Curative effect of β-blocker on various ejection fractions of patients with atrial fibrillation

  2019cites this paper
• Beta-blockers in Cardiovascular Therapy: A Review

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.

  2019cites this paper
• Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction

  2019cites this paper
• LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model

  2019cites this paper
• [Prognosis of the life of patients with chronic heart failure and atrial fibrilla-tion, depending on the control of hemodynamic parameters and tolerance to physical exertion in the background of basic therapy].

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2019cites this paper
• Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2019cites this paper
• Hypertension control after an initial cardiac event among Medicare patients with diabetes mellitus: A multidisciplinary group practice observational study

  2018cites this paper
• Can Anti-inflammatory Therapy Prevent Atrial Fibrillation in Myocardial Infarction Patients?

  2018cites this paper
• Acute Left Ventricular Unloading Reduces Atrial Stretch and Inhibits Atrial Arrhythmias.

  2018cites this paper
• Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction.

  2018cites this paper
• Non-ST-Segment Acute Coronary Syndromes.

  2018cites this paper
• 114 – Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death

  2018cites this paper
• Failing Hearts Are More Vulnerable to Sympathetic, but Not Vagal Stimulation-Induced, Atrial Fibrillation-Ameliorated with Dantrolene Treatment.

  2018cites this paper
• An Update on AMPK in Hydrogen Sulfide Pharmacology

  2017cites this paper
• Sympathetic Blockade for Dysrhythmia Management in Heart Failure: Rationale and Therapeutic Progression to Intervention

  2017cites this paper
• Atrial Fibrillation in the setting of Coronary Artery Disease : Risks and outcomes with different treatment options

  2017influential citation
• [Algorithm for the management of patients with stable coronary artery disease and high-grade ventricular arrhythmias].

  2017cites this paper
• Temporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real‐world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000–2013

  2017cites this paper
• Meta-Analysis Comparing Metoprolol and Carvedilol on Mortality Benefits in Patients With Acute Myocardial Infarction.

  2017cites this paper
• Are beta blockers still necessary for all survivors of acute myocardial infarction?

  2017cites this paper
• The Real Role of β-Blockers in Daily Cardiovascular Therapy

  2017cites this paper
• Una historia resumida. Impacto de los avances en cardiopatía isquémica

  2017cites this paper
• Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.

  2017cites this paper
• Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium

  2017cites this paper
• Ventricular Arrhythmia after Acute Myocardial Infarction: 'The Perfect Storm'.

  2017cites this paper
• Mechanisms of Arrhythmias

  2017cites this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cites this paper
• Pharmacological interventions for heart failure in people with chronic kidney disease.

  2016cites this paper
• Highlights of the Year in JACC2005

  2016cites this paper
• [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].

  2016cites this paper
• Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction

  2016cites this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cites this paper
• Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

  2016cites this paper
• Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis

  2016cites this paper
• CARDIOPROTECTIVE EFFECT OF IVABRADINE VERSUS CARVEDILOL IN RATS

  2015cites this paper
• Management of pace-terminated ventricular arrhythmias.

  2015cites this paper